---
layout: default
title: Multi-View MRI Approach for Classification of MGMT Methylation in Glioblastoma Patients
---

# Multi-View MRI Approach for Classification of MGMT Methylation in Glioblastoma Patients

**arXiv**: [2512.14232v1](https://arxiv.org/abs/2512.14232) | [PDF](https://arxiv.org/pdf/2512.14232.pdf)

**ä½œè€…**: Rawan Alyahya, Asrar Alruwayqi, Atheer Alqarni, Asma Alkhaldi, Metab Alkubeyyer, Xin Gao, Mona Alshahrani

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¤šè§†å›¾MRIæ–¹æ³•ï¼Œåˆ©ç”¨ç©ºé—´å…³ç³»å’Œæ·±åº¦å­¦ä¹ éžä¾µå…¥æ€§æ£€æµ‹èƒ¶è´¨æ¯ç»†èƒžç˜¤MGMTç”²åŸºåŒ–çŠ¶æ€ã€‚**

ðŸŽ¯ **åŒ¹é…é¢†åŸŸ**: **è§†è§‰é‡Œç¨‹è®¡**

**å…³é”®è¯**: `æ”¾å°„åŸºå› ç»„å­¦` `å¤šè§†å›¾MRI` `æ·±åº¦å­¦ä¹ ` `MGMTç”²åŸºåŒ–æ£€æµ‹` `èƒ¶è´¨æ¯ç»†èƒžç˜¤` `éžä¾µå…¥æ€§è¯Šæ–­` `ç²¾å‡†åŒ»å­¦` `è‚¿ç˜¤åˆ‡ç‰‡æå–`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šçŽ°æœ‰MGMTç”²åŸºåŒ–æ£€æµ‹ä¾èµ–ä¾µå…¥æ€§æ´»æ£€ï¼Œé£Žé™©é«˜ä¸”è€—æ—¶ï¼Œè€Œä¼ ç»Ÿ3Dæ·±åº¦å­¦ä¹ æ¨¡åž‹å‚æ•°å¤šã€æ”¶æ•›æ…¢ã€å†…å­˜éœ€æ±‚å¤§ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šæå‡ºå¤šè§†å›¾MRIæ–¹æ³•ï¼Œç»“åˆç©ºé—´å…³ç³»å’Œæ·±åº¦å­¦ä¹ ï¼Œä»Žä¸‰ä¸ªè§†å›¾æå–ä¿¡æ¯ï¼Œé¿å…å¤æ‚3Dæ¨¡åž‹ï¼Œå¹¶å¼•å…¥æ–°è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šæ–°æ–¹æ³•åœ¨å¤šä¸ªè¯„ä¼°æŒ‡æ ‡ä¸Šä¼˜äºŽçŽ°æœ‰æ–¹æ³•ï¼Œå±•ç¤ºäº†éžä¾µå…¥æ€§æ£€æµ‹çš„æ½œåŠ›ï¼Œå¹¶æä¾›äº†å¯å¤çŽ°æµç¨‹ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

MGMTå¯åŠ¨å­ç”²åŸºåŒ–çš„å­˜åœ¨æ˜¾è‘—å½±å“èƒ¶è´¨æ¯ç»†èƒžç˜¤ï¼ˆGBMï¼‰æ‚£è€…åŒ–ç–—æ•ˆæžœã€‚ç›®å‰ï¼Œç¡®è®¤MGMTå¯åŠ¨å­ç”²åŸºåŒ–ä¾èµ–äºŽä¾µå…¥æ€§è„‘è‚¿ç˜¤ç»„ç»‡æ´»æ£€ã€‚æœ¬ç ”ç©¶æŽ¢ç´¢äº†æ”¾å°„åŸºå› ç»„å­¦æŠ€æœ¯ï¼Œè¿™æ˜¯ä¸€ç§åœ¨ç²¾å‡†åŒ»å­¦ä¸­å‰æ™¯å¹¿é˜”çš„æ–¹æ³•ï¼Œæ—¨åœ¨ä»ŽåŒ»å­¦å›¾åƒä¸­è¯†åˆ«é—ä¼ æ ‡è®°ã€‚åˆ©ç”¨MRIæ‰«æå’Œæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œæˆ‘ä»¬æå‡ºäº†ä¸€ç§æ–°çš„å¤šè§†å›¾æ–¹æ³•ï¼Œè€ƒè™‘MRIè§†å›¾ä¹‹é—´çš„ç©ºé—´å…³ç³»æ¥æ£€æµ‹MGMTç”²åŸºåŒ–çŠ¶æ€ã€‚é‡è¦çš„æ˜¯ï¼Œæˆ‘ä»¬çš„æ–¹æ³•ä»Žæ‰€æœ‰ä¸‰ä¸ªè§†å›¾ä¸­æå–ä¿¡æ¯ï¼Œè€Œä¸ä½¿ç”¨å¤æ‚çš„3Dæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œé¿å…äº†é«˜å‚æ•°æ•°é‡ã€æ”¶æ•›æ…¢å’Œå¤§é‡å†…å­˜éœ€æ±‚ç­‰é—®é¢˜ã€‚æˆ‘ä»¬è¿˜å¼•å…¥äº†ä¸€ç§æ–°çš„è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯ï¼Œå¹¶åŸºäºŽå¤šä¸ªè¯„ä¼°æŒ‡æ ‡å±•ç¤ºäº†å…¶ä¼˜äºŽçŽ°æœ‰æ–¹æ³•çš„æ€§èƒ½ã€‚é€šè¿‡å°†æˆ‘ä»¬çš„æ–¹æ³•ä¸Žæœ€å…ˆè¿›æ¨¡åž‹è¿›è¡Œæ¯”è¾ƒï¼Œæˆ‘ä»¬è¯æ˜Žäº†è¯¥æ–¹æ³•çš„æœ‰æ•ˆæ€§ã€‚æ­¤å¤–ï¼Œæˆ‘ä»¬åˆ†äº«äº†å·²å‘è¡¨æ¨¡åž‹çš„å¯å¤çŽ°æµç¨‹ï¼Œé¼“åŠ±é€æ˜Žåº¦å’Œç¨³å¥è¯Šæ–­å·¥å…·çš„å¼€å‘ã€‚æˆ‘ä»¬çš„ç ”ç©¶çªå‡ºäº†éžä¾µå…¥æ€§æ–¹æ³•è¯†åˆ«MGMTå¯åŠ¨å­ç”²åŸºåŒ–çš„æ½œåŠ›ï¼Œå¹¶æœ‰åŠ©äºŽæŽ¨è¿›GBMæ²»ç–—ä¸­çš„ç²¾å‡†åŒ»å­¦ã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

è®ºæ–‡æå‡ºä¸€ä¸ªå¤šè§†å›¾MRIæ¡†æž¶ï¼Œç”¨äºŽMGMTç”²åŸºåŒ–åˆ†ç±»ã€‚æ•´ä½“æ¡†æž¶åŸºäºŽæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œä»ŽMRIçš„ä¸‰ä¸ªè§†å›¾ï¼ˆå¦‚è½´å‘ã€å† çŠ¶ã€çŸ¢çŠ¶ï¼‰æå–ç‰¹å¾ï¼Œå¹¶è€ƒè™‘è§†å›¾é—´çš„ç©ºé—´å…³ç³»è¿›è¡Œèžåˆï¼Œä»¥å¢žå¼ºä¿¡æ¯è¡¨ç¤ºã€‚å…³é”®æŠ€æœ¯åˆ›æ–°ç‚¹åŒ…æ‹¬ï¼šé¿å…ä½¿ç”¨å¤æ‚3Dæ¨¡åž‹ï¼Œé€šè¿‡å¤šè§†å›¾æ–¹æ³•å‡å°‘å‚æ•°å’Œå†…å­˜éœ€æ±‚ï¼›å¼•å…¥æ–°çš„è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯ï¼Œæé«˜æ•°æ®é¢„å¤„ç†æ•ˆçŽ‡ã€‚ä¸ŽçŽ°æœ‰æ–¹æ³•çš„ä¸»è¦åŒºåˆ«åœ¨äºŽï¼šä¼ ç»Ÿæ–¹æ³•å¸¸ä¾èµ–å•ä¸€è§†å›¾æˆ–å¤æ‚3Dæ¨¡åž‹ï¼Œè€Œæœ¬æ–¹æ³•é€šè¿‡å¤šè§†å›¾èžåˆå’Œç®€åŒ–æž¶æž„ï¼Œåœ¨ä¿æŒæ€§èƒ½çš„åŒæ—¶é™ä½Žäº†è®¡ç®—è´Ÿæ‹…ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

å®žéªŒç»“æžœæ˜¾ç¤ºï¼Œæ–°æ–¹æ³•åœ¨MGMTç”²åŸºåŒ–åˆ†ç±»ä»»åŠ¡ä¸­ï¼ŒåŸºäºŽå¤šä¸ªè¯„ä¼°æŒ‡æ ‡ï¼ˆå¦‚å‡†ç¡®çŽ‡ã€çµæ•åº¦ï¼‰ä¼˜äºŽçŽ°æœ‰æœ€å…ˆè¿›æ¨¡åž‹ã€‚è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯çš„å¼•å…¥æ˜¾è‘—æå‡äº†æ€§èƒ½ï¼ŒåŒæ—¶å¤šè§†å›¾æ¡†æž¶é¿å…äº†3Dæ¨¡åž‹çš„é«˜è®¡ç®—æˆæœ¬ï¼Œå®žçŽ°äº†é«˜æ•ˆä¸”ç¨³å¥çš„æ£€æµ‹ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶åœ¨ç²¾å‡†åŒ»å­¦é¢†åŸŸæœ‰é‡è¦åº”ç”¨ï¼Œç‰¹åˆ«æ˜¯èƒ¶è´¨æ¯ç»†èƒžç˜¤ï¼ˆGBMï¼‰æ²»ç–—ã€‚é€šè¿‡éžä¾µå…¥æ€§MRIæ‰«ææ£€æµ‹MGMTç”²åŸºåŒ–çŠ¶æ€ï¼Œå¯è¾…åŠ©ä¸´åºŠå†³ç­–ï¼Œä¼˜åŒ–åŒ–ç–—æ–¹æ¡ˆï¼Œå‡å°‘æ‚£è€…æ´»æ£€é£Žé™©ã€‚æ­¤å¤–ï¼Œæ–¹æ³•å¯æŽ¨å¹¿è‡³å…¶ä»–è„‘è‚¿ç˜¤æˆ–ç™Œç—‡çš„é—ä¼ æ ‡è®°æ£€æµ‹ï¼ŒæŽ¨åŠ¨ä¸ªæ€§åŒ–åŒ»ç–—å‘å±•ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> The presence of MGMT promoter methylation significantly affects how well chemotherapy works for patients with Glioblastoma Multiforme (GBM). Currently, confirmation of MGMT promoter methylation relies on invasive brain tumor tissue biopsies. In this study, we explore radiogenomics techniques, a promising approach in precision medicine, to identify genetic markers from medical images. Using MRI scans and deep learning models, we propose a new multi-view approach that considers spatial relationships between MRI views to detect MGMT methylation status. Importantly, our method extracts information from all three views without using a complicated 3D deep learning model, avoiding issues associated with high parameter count, slow convergence, and substantial memory demands. We also introduce a new technique for tumor slice extraction and show its superiority over existing methods based on multiple evaluation metrics. By comparing our approach to state-of-the-art models, we demonstrate the efficacy of our method. Furthermore, we share a reproducible pipeline of published models, encouraging transparency and the development of robust diagnostic tools. Our study highlights the potential of non-invasive methods for identifying MGMT promoter methylation and contributes to advancing precision medicine in GBM treatment.

